基质辅助激光解吸电离飞行时间质谱在结核病领域的应用进展

doi:10.3969/j.issn.1000-6621.2019.11.014

摘要/Abstract

摘要：

基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)具有高通量、高速度、自动化等优点,成为生物大分子研究的重要工具。其在临床研究领域取得显著进展,在结核病研究领域的作用也日益凸显。作者主要介绍了MALDI-TOF MS在分枝杆菌菌种鉴定、结核病耐药性研究、结核病血清标志物的筛选、结核病易感基因多态性检测和抗结核药物代谢研究方面的应用进展,以加强对MALDI-TOF MS在结核病研究领域的认识。

关键词: 结核, 光谱法,质量,基质辅助激光解吸电离, 综述文献(主题)

Abstract:

Matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), which has the advantages of high throughput, high speed, automation, etc., has become an important tool for bio-macromolecular research. It has made remarkable progress on clinical research and has become increasingly prominent in the field of tuberculosis research. This review mainly introduced the application of MALDI-TOF MS in the identification of mycobacterium, research of drug-resistance tuberculosis, screening of tuberculosis serum markers, detection of tuberculosis susceptibility gene polymorphisms and research of anti-tuberculosis drug metabolism in order to strengthen the understanding to MALDI-TOF MS in the field of tuberculosis research.

Key words: Tuberculosis, Spectrometry, mass, matrix-assisted laser desorption-ionization, Review literature as topic

穆成,王春花. 基质辅助激光解吸电离飞行时间质谱在结核病领域的应用进展[J]. 中国防痨杂志, 2019, 41(11): 1223-1226. doi: 10.3969/j.issn.1000-6621.2019.11.014

MU Cheng,WANG Chun-hua. Progress on the application of matrix-assisted laser desorption ionization-time of flight mass spectrometry in the field of tuberculosis research[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1223-1226. doi: 10.3969/j.issn.1000-6621.2019.11.014

参考文献 25

[1]	Domon B, Aebersold R . Mass spectrometry and protein analysis. Science, 2006,312(5771):212-217. doi: 10.1126/science.1124619 URL pmid: 16614208
[2]	Singhal N, Kumar M, Kanaujia PK , et al. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol, 2015,6:791. doi: 10.3389/fmicb.2015.00791 URL pmid: 26300860
[3]	Diamandis EP . Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics, 2004,3(4):367-378. doi: 10.1074/mcp.R400007-MCP200 URL pmid: 14990683
[4]	Mesaros C, Blair IA . Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease. Clin Proteomics, 2016,13:20. doi: 10.1186/s12014-016-9121-1 URL pmid: 27713681
[5]	Bowlus CL, Seeley EH, Roder J , et al. In situ mass spectrometry of autoimmune liver diseases. Cell Mol Immunol, 2011,8(3):237-242. doi: 10.1038/cmi.2010.72 URL pmid: 21258365
[6]	World Health Organization . Global tuberculosis report 2018. Geneva: World Health Organization, 2018. doi: 10.1080/21645515.2019.1693720 URL pmid: 31730397
[7]	Cao Y, Wang L, Ma P , et al. Accuracy of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of mycobacteria: a systematic review and meta-analysis. Sci Rep, 2018,8(1):4131. doi: 10.1038/s41598-018-22642-w URL pmid: 29515167
[8]	李松, 姚妍娇, 屈平华 , 等. 基质辅助激光解析电离飞行时间质谱技术对非结核分枝杆菌的鉴定与分型. 中华检验医学杂志, 2018,41(2):109-115.
[9]	Şamlı A , I ˙ lki A. Comparison of MALDI-TOF MS, nucleic acid hybridization and the MPT64 immunochromatographic test for the identification of M.tuberculosis and non-tuberculosis Mycobacterium species . New Microbiol, 2016,39(4):259-263. URL pmid: 27551724
[10]	Singh A, Gopinath K, Sharma P , et al. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant. Indian J Med Res, 2015,141(1):27-45. doi: 10.4103/0971-5916.154492 URL pmid: 25857493
[11]	Lata M, Sharma D, Kumar B , et al. Proteome analysis of ofloxacin and moxifloxacin induced Mycobacterium tuberculosis isolates by proteomic approach. Protein Pept Lett, 2015,22(4):362-371. doi: 10.2174/0929866522666150209113708 URL pmid: 25666036
[12]	Sharma D, Kumar B, Lata M , et al. Comparative proteomic analysis of aminoglycosides resistant and susceptible Mycobacterium tuberculosis clinical isolates for exploring potential drug targets. PLoS One, 2015,10(10):e0139414. doi: 10.1371/journal.pone.0139414 URL pmid: 26436944
[13]	Li C, He X, Li H , et al. Discovery and verification of serum differential expression proteins for pulmonary tuberculosis. Tuberculosis (Edinb), 2015,95(5):547-554. doi: 10.1016/j.tube.2015.06.001 URL pmid: 26276261
[14]	陈汐濛, 贾兴旺, 雷红 , 等. 应用基质辅助激光解吸电离飞行时间质谱行骨关节结核血清鉴别标志物的初探. 中华检验医学杂志, 2019,42(6):420-426.
[15]	Caws M, Thwaites G, Dunstan S , et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog, 2008,4(3):e1000034. doi: 10.1371/journal.ppat.1000034 URL pmid: 18369480
[16]	周莹, 黄迪迪, 何丹 , 等. SP110基因rs11679983A/G多态性与中国南方汉族肺结核易感性研究. 中华医院感染学杂志, 2016,26(7):1477-1479.
[17]	汪文斐, 张国良, 杨帆 , 等. 飞行时间质谱与TaqMan探针技术在结核病易感性相关基因单核苷酸多态性筛选中的应用. 中国防痨杂志, 2014,36(6):434-439. doi: 10.3969/j.issn.1000-6621.2014.06.006 URL
[18]	Bragina EY, Babushkina NP, Garaeva AF , et al. Impact of the Polymorphism of the PACRG and CD80 Genes on the Development of the Different Stages of Tuberculosis Infection. Iran J Med Sci, 2019,44(3):236-244. URL pmid: 31182890
[19]	Caprioli RM, Farmer TB, Gile J . Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem, 1997,69(23):4751-4760. doi: 10.1021/ac970888i URL pmid: 9406525
[20]	Vestal M, Li L, Dobrinskikh E , et al. Rapid MALDI-TOF molecular imaging: Instrument enhancements and their practical consequences. J Mass Spectrom, 2019. doi: 10.1002/jms.4484 URL pmid: 31786817
[21]	Prideaux B , ElNaggar MS, Zimmerman M, et al. Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling. Int J Mass Spectrom, 2015,377:699-708. doi: 10.1016/j.ijms.2014.08.024 URL pmid: 26185484
[22]	Prentice BM, Chumbley CW, Caprioli RM . Absolute quantification of rifampicin by MALDI imaging mass spectrometry using multiple TOF/TOF events in a single laser shot. J Am Soc Mass Spectrom, 2017,28(1):136-144. doi: 10.1007/s13361-016-1501-2 URL pmid: 27655354
[23]	Notari S, Mancone C, Sergi M , et al. Determination of antituberculosis drug concentration in human plasma by MALDI-TOF/TOF. IUBMB Life, 2010,62(5):387-393. doi: 10.1002/iub.321 URL pmid: 20306514
[24]	Gopal J, Muthu M, Chun SC , et al. State-of-the-art nanoplatform-integrated MALDI-MS impacting resolutions in urinary proteomics. Proteomics Clin Appl, 2015,9(5/6):469-481. doi: 10.1002/prca.201400182 URL pmid: 25736343
[25]	Soo PC, Horng YT, Chen AT , et al. Validation of nanodiamond-extracted CFP-10 antigen as a biomarker in clinical isolates of Mycobacterium tuberculosis complex in broth culture media. Tuberculosis (Edinb), 2015,95(5):620-624. doi: 10.1016/j.tube.2015.05.008 URL pmid: 26071665